Probiotics versus Rifaximin as Adjuvant Therapy for Helicobacter pylori Eradication
Background and study aim: Helicobacter pylori infection, affecting over 50% of the global population, is a major cause of peptic ulcers and gastric cancer. Standard triple therapy (proton pump inhibitor [PPI], clarithromycin, amoxicillin) achieves modest eradication rates (~70%) but often causes gas...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Zagazig University, Faculty of Medicine, Endemic and Tropical Medicine Department
2025-12-01
|
| Series: | Afro-Egyptian Journal of Infectious and Endemic Diseases |
| Subjects: | |
| Online Access: | https://aeji.journals.ekb.eg/article_454389_4ecb9ab7c5f57061364f83f2fbeb978d.pdf |
| Tags: |
No Tags, Be the first to tag this record!
|